You have 9 free searches left this month | for more free features.

Best supportive care (BSC)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

SARS-CoV 2, COVID-19, Coronavirus Disease 2019 Trial in France (Masitinib, Isoquercetin, Best Supportive Care)

Recruiting
  • SARS-CoV 2
  • +2 more
  • Aix-en-Provence, France
  • +5 more
Jun 20, 2022

Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)

Recruiting
  • Mast Cell Activation Syndrome
  • Masitinib 4.5 mg/kg/day
  • +3 more
  • Weldon Spring, Missouri
  • +1 more
Jul 18, 2022

Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

Active, not recruiting
  • Thalassemia
  • Los Angeles, California
  • +16 more
Aug 16, 2022

Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +40 more
Mar 3, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (capecitabine, Best supportive care (BSC))

Completed
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    SunYat-senU
Jul 30, 2020

Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Covid19 Trial in Mumbai, New Delhi (Itolizumab IV infusion, Best

Completed
  • Acute Respiratory Distress Syndrome
  • +2 more
  • Itolizumab IV infusion
  • Best supportive care (BSC)
  • Mumbai, India
  • +3 more
Jun 10, 2021

Hepatocellular Carcinoma Trial (biological, drug, other)

Completed
  • Hepatocellular Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 30, 2022

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])

Recruiting
  • Platinum-sensitive Ovarian Cancer
  • Relapsed Ovarian Cancer
  • OSE2101
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Angers, France
  • +27 more
Jul 25, 2022

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 9, 2023

Anemia Trial in Worldwide (biological, drug, other)

Recruiting
  • Anemia
  • Luspatercept
  • +2 more
  • Halifax, Nova Scotia, Canada
  • +11 more
Jan 3, 2023

Bone Sarcoma, Osteosarcoma Trial in France (Treatment by regorafenib and best supportive care, Treatment by and best supportive

Recruiting
  • Bone Sarcoma
  • Osteosarcoma
  • Treatment by regorafenib and best supportive care
  • Treatment by placebo and best supportive care
  • Besançon, France
  • +13 more
May 12, 2022

Urothelial Carcinoma Trial in Italy (Niraparib, Best supportive care)

Completed
  • Urothelial Carcinoma
  • Alba, Italy
  • +19 more
May 16, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, Best supportive/best standard of care

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 2, 2023

Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))

Active, not recruiting
  • Leukemia
  • Azacitidine (AZA) Days 1 - 3
  • +3 more
  • Tampa, Florida
  • +5 more
Jul 21, 2020

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

Colorectal Cancer Trial in China (fruquintinib, )

Completed
  • Colorectal Cancer
  • Beijing, Beijing, China
  • +4 more
Jun 12, 2020

Low Anterior Resection Syndrome Trial in Vilnius (Transanal irrigation, Best supportive care)

Recruiting
  • Low Anterior Resection Syndrome
  • Transanal irrigation
  • Best supportive care
  • Vilnius, Lithuania
    National Cancer Institute
Jun 27, 2023

Feasibility of Best Supportive Care Delivery Trial (Best Supportive Care Checklist)

Completed
  • Feasibility of Best Supportive Care Delivery
  • Best Supportive Care Checklist
  • (no location specified)
Feb 27, 2020

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte, Lancaster, Upland (Best Practice, Comprehensive

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Best Practice
  • +5 more
  • Duarte, California
  • +2 more
Aug 28, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Supportive Care, Survey

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Best Practice
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 17, 2023

Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best

Completed
  • Advanced NET of GI Origin
  • +2 more
  • La Jolla, California
  • +96 more
Jul 13, 2021

Acute Myeloid Leukemia Trial in Japan (Oral Azacitidine, Placebo)

Recruiting
  • Acute Myeloid Leukemia
  • Oral Azacitidine
  • Placebo
  • Nagoya, Aichi, Japan
  • +30 more
May 25, 2022

Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:

Active, not recruiting
  • Urothelial Cancer
  • Avelumab
  • +2 more
  • Aurora, Colorado
  • +370 more
Oct 24, 2022